1-20 of 271 Search Results for

brand

Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Article
J Health Polit Policy Law (1980) 5 (3): 523–534.
Published: 01 June 1980
... of deontology and teleology. Since both modes of analysis have deficiencies, the need for a synthesis using economic and noneconomic measures is suggested. Copyright © 1980 by the Dept. of Health Administration, Duke University 1980 Occupational Health Ethics: OSHA and the Courts Sherry I. Brand...
Journal Article
J Health Polit Policy Law (1995) 20 (4): 1051–1061.
Published: 01 August 1995
Journal Article
J Health Polit Policy Law (2013) 38 (6): 1193–1199.
Published: 01 December 2013
Journal Article
J Health Polit Policy Law (2017) 42 (1): 197–204.
Published: 01 February 2017
Journal Article
J Health Polit Policy Law (1984) 9 (1): 103–124.
Published: 01 February 1984
Journal Article
J Health Polit Policy Law (1977) 2 (1): 79–99.
Published: 01 February 1977
Journal Article
J Health Polit Policy Law (2015) 40 (6): 1179–1202.
Published: 01 December 2015
... consumers place on brand name, the perceived quality of care and customer service, and differences in provider networks. We reviewed the health plan quality ratings for Covered California plans but chose not to include this data in the models because the ratings did not vary much by plan or region...
FIGURES
Journal Article
J Health Polit Policy Law (2013) 38 (3): 573–597.
Published: 01 June 2013
... replacing brand names entirely with INNs. Instead, we propose dual use of brand names and INNs in prescribing, as in drug labeling. © 2013 by Duke University Press 2013 References Allan F. M. 1974 . “Standardization of Drug Names.” Journal of the American Medical Association 229...
Image
Published: 01 October 2019
Figure 4 Number of advertisements placed per year for erectile dysfunction category and individual brands, 2006–2015. Source : Nielsen ( 2016 ) Monitor-Plus. Notes : The double-ended arrows represent the average number of advertisements for the category (22,986), and for each brand (Viagra More
Journal Article
J Health Polit Policy Law (2022) 47 (1): 27–61.
Published: 01 February 2022
... and the representation of physicians. Furthermore, the displayed versus actual degree of inspiration varied significantly, with a branding strategy in Germany (high display of foreign influence) and the inverse picture in France (high degree of actual inspiration). Conclusions: This analysis has applied the dual...
Journal Article
J Health Polit Policy Law (2022) 47 (6): 629–648.
Published: 01 December 2022
... by manufacturers, which are harder to observe, change the relative importance of the sources of revenue growth? Methods: This study uses data from SSR Health LLC to address these research questions using decomposition methods that analyze list prices, prices net of rebates, and sales for branded pharmaceutical...
FIGURES | View All (4)
Includes: Supplementary data
Journal Article
J Health Polit Policy Law (1979) 4 (2): 155–175.
Published: 01 April 1979
... be demonstrated between the brand name and generic drug. This paper examines the political evolution and rationale for this program and explores the issues surrounding the ongoing controversy regarding publicly financed programs offering drug benefits. The authors speculate that the government's first attempt...
Journal Article
J Health Polit Policy Law (2022) 47 (6): 815–833.
Published: 01 December 2022
... are those that do not interfere with prescribing. However, recent evidence has shown that most payments influence physician prescribing, driving higher prescription drug costs by increasing use of brand-name and low-value drugs. This evidence implies that many payments that are currently commonplace could...
Image
Published: 01 October 2019
Figure 2 Percentage of television occurrences in violation of target audience (age 18+) for ED category and individual brands, first quarter 2010 through fourth quarter 2015. Source : Nielsen ( 2016 ) Monitor-Plus. Notes : The line at Q1 2013 represents the publication of Arnold and Oakley More
Image
Published: 01 October 2019
Figure 3 Number of impressions for audience members under 18 years of age, first quarter 2010 through fourth quarter 2015. Source : Nielsen ( 2016 ) Monitor-Plus. Notes : The line at Q1 2013 represents the publication of Arnold and Oakley 2013 , disclosing noncompliance by the brands More
Image
Published: 01 October 2019
Figure 1 Direct-to-consumer media spending for erectile dysfunction (ED) category and Viagra and Cialis brands (in US$ millions): 2010–17. Source : Kantar Media 2017 . Notes : Levitra ceased extensive marketing efforts in early 2010 and is thus not represented on this chart. Beginning More
Journal Article
J Health Polit Policy Law (2019) 44 (5): 765–787.
Published: 01 October 2019
...Figure 4 Number of advertisements placed per year for erectile dysfunction category and individual brands, 2006–2015. Source : Nielsen ( 2016 ) Monitor-Plus. Notes : The double-ended arrows represent the average number of advertisements for the category (22,986), and for each brand (Viagra...
FIGURES | View All (4)
Journal Article
J Health Polit Policy Law (2008) 33 (5): 975–978.
Published: 01 October 2008
... recent data collected by one of us (Garis). Data from the first quarter of 2008 suggest that some PBMs take no spreads. (These findings include the fact that some spreads are zero or even negative. Spreads are negative when PBMs reimburse pharmacies more than they charge employers on brand drugs...
Journal Article
J Health Polit Policy Law (2022) 47 (6): 853–877.
Published: 01 December 2022
.... For non-LIS beneficiaries, manufacturers of brand-name drugs are now required to pay 70% of costs incurred in the coverage gap, while plans are responsible for 5% of the cost of these drugs. Additionally, plans are responsible for 75% of generic drug costs, leaving non-LIS beneficiaries with 25...
FIGURES | View All (8)
Journal Article
J Health Polit Policy Law (2008) 33 (5): 965–973.
Published: 01 October 2008
.... To the extent it is equally or more efficacious, it will be included only if the total net price (discounts and rebates) is equal to or more favorable than existing therapies in the class. The actual rebate values associated with specific products made by brand manufacturers are highly confidential...